Damaged protein identified as early biomarker for Alzheimer's

February, 2010

Evidence that levels of damaged tau protein in the cerebrospinal fluid is associated with atrophy in the medial temporal lobe may help diagnose Alzheimer’s early.

A study involving 57 cognitively healthy older adults has found that those who showed decreased memory performance two years later (20 of the 57) had higher baseline levels of phosphorylated tau231 in the cerebrospinal fluid, and more atrophy in the medial temporal lobe. Higher levels of damaged tau protein were associated with reductions in medial temporal lobe gray matter. The finding may be useful in early diagnosis of Alzheimer’s disease.

Reference: 

Related News

I’ve spoken before about the association between hearing loss in old age and dementia risk.

The study involved 74 non-smokers with amnestic

More data from the long-running Mayo Clinic Study of Aging has revealed that, in this one part of the U.S.

We know that physical exercise greatly helps you prevent cognitive decline with aging. We know that mental stimulation also helps you prevent age-related cognitive decline. So it was only a matter of time before someone came up with a way of combining the two.

The age at which cognitive decline begins has been the subject of much debate. The Seattle longitudinal study has provided most of the evidence that it doesn’t begin until age 60.

The study involved 104 healthy older adults (average age 87) participating in the Oregon Brain Aging Study.

Growing evidence points to greater education and mentally stimulating occupations and activities providing a

A study involving 159 older adults (average age 76) has confirmed that the amount of brain tissue in specific regions is a predictor of Alzheimer’s disease development.

The olfactory bulb is in the oldest part of our brain. It connects directly to the

Why is diabetes associated with cognitive impairment and even dementia in older adults? New research pinpoints two molecules that trigger a cascade of events that end in poor blood flow and brain atrophy.

Pages

Subscribe to Latest newsSubscribe to Latest newsSubscribe to Latest health newsSubscribe to Latest news